UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer

NPJ breast cancer, 2022-04, Vol.8 (1), p.46-46, Article 46

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement

Journal of the American College of Surgeons, 2024-01, Vol.238 (1), p.1-9

2024

Link zum Volltext

Verfügbarkeit prüfen

Integrating poly(ADP-ribose) polymerase (PARP) inhibitors in the treatment of early breast cancer

Current opinion in oncology, 2019-05, Vol.31 (3), p.247

2019

Link zum Volltext

Verfügbarkeit prüfen

Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer

Oncotarget, 2024-03, Vol.15, p.238-247

2024

Link zum Volltext

Verfügbarkeit prüfen

Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation

The Journal of immunology (1950), 2018-09, Vol.201 (5), p.1389-1399

2018

Link zum Volltext

Verfügbarkeit prüfen

A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells

Cytotherapy (Oxford, England), 2016-08, Vol.18 (8), p.985-994

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer

Breast cancer research and treatment, 2023-06, Vol.199 (3), p.457-469

2023

Link zum Volltext

Verfügbarkeit prüfen

Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes

Clinical cancer research, 2019-04, Vol.25 (8), p.2610-2620

2019

Link zum Volltext

Verfügbarkeit prüfen

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma

Npj genomic medicine, 2017-04, Vol.2 (1), p.1-11, Article 10

2017

Link zum Volltext

Verfügbarkeit prüfen

Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL

Blood, 2015-05, Vol.125 (19), p.2958-2967

2015

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma

Clinical cancer research, 2018-07, Vol.24 (14), p.3386-3396

2018

Link zum Volltext

Verfügbarkeit prüfen

PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia

Cytotherapy (Oxford, England), 2016-08, Vol.18 (8), p.995-1001

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2392: Genomic and immune heterogeneity in synchronous melanoma metastases is associated with differential tumor growth and response to therapy

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2392-2392

2016

Link zum Volltext

Verfügbarkeit prüfen

Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells

Cancer immunology research, 2017-04, Vol.5 (4), p.319-329

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-14-14: Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2 negative stage II-III breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-14-14

2022

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome

Biology of blood and marrow transplantation, 2016-10, Vol.22 (10), p.1792-1800

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract B59: Co-evolution between tumor cells and immune system in the setting of T-cell immunotherapy

Cancer immunology research, 2020-04, Vol.8 (4_Supplement), p.B59-B59

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1516: Deep profiling of T-cell repertoire and tumor heterogeneity in chronic lymphocytic leukemia patients following allogeneic T-cell therapy

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.1516-1516

2020

Link zum Volltext

Verfügbarkeit prüfen

Engineering a TCR-like Anti-PR1/HLA-A2 Antibody Scfv in a Novel Chimeric Antigen Receptor (CAR) to Redirect T Cells to Eliminate Myeloid Leukemia

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S202-S203

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-222: Long-term subclonal evolution of CLL from immune selective pressure after allogeneic stem cell transplant and donor lymphocyte infusion

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.LB-222-LB-222

2015

Link zum Volltext

Verfügbarkeit prüfen

Adoptive T-cell therapy for Leukemia

Molecular and cellular therapies, 2014-08, Vol.2 (1), p.25-25

2014

Link zum Volltext

Verfügbarkeit prüfen

Targeting the MAGE A3 antigen in pancreatic cancer: TOPICS IN PANCREATIC SURGERY: A FESTSCHRIFT HONORING ANDREW L. WARSHAW

Surgery, 2012, Vol.152 (3)

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 958: Treatment with a selective inhibitor of BRAFV600E increases melanocyte antigen expression and CD8 T cell infiltrate in tumors of patients with metastatic melanoma

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.958-958

2011

Link zum Volltext

Verfügbarkeit prüfen

Long-term Outcomes After Treatment with Clofarabine ± Fludarabine with Once Daily IV Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS

Biology of blood and marrow transplantation, 2016-07, Vol.22 (10), p.1792-1800

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Humans
(11)
Oncology
(7)
Female
(6)
Hematology
(5)
Adult
(4)
Animals
(4)
Mice
(4)
Breast Neoplasms - Drug Therapy
(3)
Hla-A2 Antigen - Immunology
(3)
Immunology
(3)
Immunotherapy
(3)
Leukemia
(3)
Leukemia, Myeloid, Acute - Therapy
(3)
Myeloblastin - Immunology
(3)
T-Lymphocytes, Cytotoxic - Immunology
(3)
T-Lymphocytes, Cytotoxic - Metabolism
(3)
Tumors
(3)
Acute Myeloid Leukemia
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer

Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement

Integrating poly(ADP-ribose) polymerase (PARP) inhibitors in the treatment of early breast cancer

Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2-negative stage II-III breast cancer

Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation

A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells

A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer

Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma

Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL

Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma

Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target

PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia

Abstract 2392: Genomic and immune heterogeneity in synchronous melanoma metastases is associated with differential tumor growth and response to therapy

Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells

Abstract P2-14-14: Durvalumab and tremelimumab before surgery in patients with hormone receptor positive, HER2 negative stage II-III breast cancer

Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome

Abstract B59: Co-evolution between tumor cells and immune system in the setting of T-cell immunotherapy

Abstract 1516: Deep profiling of T-cell repertoire and tumor heterogeneity in chronic lymphocytic leukemia patients following allogeneic T-cell therapy

Engineering a TCR-like Anti-PR1/HLA-A2 Antibody Scfv in a Novel Chimeric Antigen Receptor (CAR) to Redirect T Cells to Eliminate Myeloid Leukemia

Abstract LB-222: Long-term subclonal evolution of CLL from immune selective pressure after allogeneic stem cell transplant and donor lymphocyte infusion

Adoptive T-cell therapy for Leukemia

Targeting the MAGE A3 antigen in pancreatic cancer: TOPICS IN PANCREATIC SURGERY: A FESTSCHRIFT HONORING ANDREW L. WARSHAW

Abstract 958: Treatment with a selective inhibitor of BRAFV600E increases melanocyte antigen expression and CD8 T cell infiltrate in tumors of patients with metastatic melanoma

Long-term Outcomes After Treatment with Clofarabine ± Fludarabine with Once Daily IV Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and MDS

Suchergebnisse filtern